Get the Stockscreener App
0.6571
3.14%
0.02
After Hours:
.67
0.0129
+1.96%
Femasys Inc stock is traded at $0.6571, with a volume of 91.38M.
It is up +3.14% in the last 24 hours and up +4.29% over the past month.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
See More
Previous Close:
$0.6371
Open:
$0.8054
24h Volume:
91.38M
Relative Volume:
13.76
Market Cap:
$21.41M
Revenue:
$950.10K
Net Income/Loss:
$-16.69M
P/E Ratio:
-0.7917
EPS:
-0.83
Net Cash Flow:
$-15.16M
1W Performance:
-7.33%
1M Performance:
+4.29%
6M Performance:
-43.35%
1Y Performance:
-47.85%
1-Day Range:
$0.62
$0.8793
1-Week Range:
$0.603
$0.8793
52-Week Range:
$0.3067
$1.80
Femasys Inc Stock (FEMY) Company Profile
Name
Femasys Inc
Sector
Industry
Phone
770-500-3910
Address
3950 JOHNS CREEK COURT, SUWANEE
Compare FEMY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
0.6571 | 27.40M | 950.10K | -16.69M | -15.16M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
544.21 | 189.40B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
177.30 | 51.22B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
73.88 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
248.95 | 36.04B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
279.78 | 20.29B | 2.96B | 487.70M | 344.00M | 6.6758 |
Femasys Inc Stock (FEMY) Latest News
Femasys Stock Sparks Retail Frenzy After FDA Clears Final Phase Of FemBloc Trial And $58M Financing - Stocktwits
Can Femasys Inc. stock reach $100 price targetIPO Watch & Accurate Entry and Exit Point Alerts - newser.com
Femasys Secures Fda Approval to Advance Final Fembloc Trial Phase and $12 Million Financing, with Potential to Reach $58 Million - MarketScreener
Femasys Inc. announced that it expects to receive $12 million in funding - MarketScreener
Femasys gets FDA OK for final FemBloc trial, secures $12M financing, stock surges - MSN
Femasys Receives FDA Approval for FemBloc Trial - TipRanks
Applying Elliott Wave Theory to Femasys Inc.Weekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com
Femasys Inc Secures FDA Approval for Final FemBloc Trial Phase - TradingView
FDA approves Femasys to continue pivotal trial for non-surgical birth control - Investing.com
Femasys secures FDA approval to advance final FemBloc trial phase - TipRanks
Femasys Inc. Advances FemBloc Toward FDA Approval with Successful Trial Completion and $12 Million Financing - Quiver Quantitative
Why Femasys Inc. stock is considered a top pickMarket Movement Recap & Expert Approved Momentum Ideas - newser.com
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, ... - Caledonian Record
Femasys Secures FDA Approval to Advance Final FemBloc® - GlobeNewswire
Exit strategy if you’re trapped in Femasys Inc.2025 Breakouts & Breakdowns & Technical Pattern Based Signals - newser.com
Is Femasys Inc. stock a safe haven assetPortfolio Update Report & Long-Term Safe Investment Plans - newser.com
Is Femasys Inc. forming a bottoming base2025 Volatility Report & Long-Term Growth Stock Strategies - newser.com
Femasys Meets Nasdaq Equity Requirement After Offering - MSN
Custom watchlist performance reports with Femasys Inc.Earnings Overview Summary & Accurate Buy Signal Notifications - newser.com
Will Femasys Inc. stock continue upward momentum2025 Top Gainers & Daily Price Action Insights - newser.com
What margin trends mean for Femasys Inc. stockTrade Risk Report & Daily Profit Maximizing Tips - newser.com
Is Femasys Inc. stock affected by interest rate hikesPortfolio Risk Summary & Free Growth Oriented Trading Recommendations - newser.com
What to do if you’re stuck in Femasys Inc.Quarterly Investment Review & Free Expert Approved Momentum Trade Ideas - newser.com
Will Femasys Inc. stock benefit from commodity pricesEntry Point & High Accuracy Trade Signal Alerts - newser.com
Is Femasys Inc. stock positioned well for digital economyPortfolio Update Summary & Consistent Profit Trading Strategies - newser.com
How institutional buying supports Femasys Inc. stockWeekly Stock Report & Risk Managed Investment Strategies - newser.com
Why Femasys Inc. stock is favored by pension fundsTrade Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
Combining machine learning predictions for Femasys Inc.Stock Surge & Weekly High Return Stock Opportunities - newser.com
Applying Wyckoff theory to Femasys Inc. stockEarnings Risk Report & High Return Stock Watch Alerts - newser.com
Femasys Inc Stock (FEMY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.41%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):